Sagopilone
Sagopilone (ZK-EPO) demonstrated antitumor activity in human orthotopic glioma models both in vitro and in vivo[1].
Product Specifications
CAS Number
305841-29-6
Product Name Alternative
ZK-EPO; ZK 219477
UNSPSC
12352005
Hazard Statement
H300-H341-H361
Target
Microtubule/Tubulin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sagopilone.html
Smiles
O=C(C[C@H](O)C1(C)C)O[C@H](C2=CC=C(SC(C)=N3)C3=C2)C[C@]4([H])O[C@]4(C)CCC[C@H](C)[C@H](O)[C@@H](CC=C)C1=O
Molecular Formula
C30H41NO6S
Molecular Weight
543.71
Precautions
P264-P270-P280-P330-P405-P501
References & Citations
[1]Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A544458-25MG 25 mg
Allyl 2-Acetamido-2-deoxy-Beta-D-glucopyranoside
Sign In for Pricing
View Details 
BNC472056-500 1x 500 µL
CD7 (T-Cell Leukemia Marker) (CD7/3737), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
